HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
11.45
+0.22 (1.96%)
May 29, 2026, 4:00 PM EDT - Market closed
HUTCHMED (China) Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 457.73 | 38.17 | 101.09 | -360.39 | -167.04 |
Depreciation & Amortization | 13.31 | 12.34 | 8.21 | 8.66 | 7.19 |
Stock-Based Compensation | 15.29 | 21.61 | 36.6 | 30.59 | 41.99 |
Other Adjustments | -491.32 | -13.06 | 1.43 | 13.01 | -125.72 |
Change in Receivables | 28.86 | -38.55 | -21.34 | -14.45 | -35.63 |
Changes in Inventories | 9.54 | -0.77 | 4.14 | -21.21 | -16 |
Changes in Accounts Payable | 3.01 | 6.19 | -32.54 | 29.94 | 9.57 |
Changes in Accrued Expenses | -48.55 | 2.43 | -4.41 | 52.63 | 66.22 |
Changes in Income Taxes Payable | 1.2 | 3.61 | 0.78 | -19.17 | 6.9 |
Changes in Unearned Revenue | -49.56 | -25.97 | 119.81 | 0.39 | 11.07 |
Changes in Other Operating Activities | -4.17 | -5.51 | 5.49 | 11.42 | -2.77 |
Operating Cash Flow | -64.66 | 0.5 | 219.26 | -268.6 | -204.22 |
Operating Cash Flow Growth | - | -99.77% | - | - | - |
Capital Expenditures | -14.15 | -17.93 | -32.61 | -36.66 | -16.4 |
Sale of Property, Plant & Equipment | 0.03 | - | - | - | - |
Purchases of Intangible Assets | -10 | - | - | - | -0.36 |
Purchases of Investments | -2,742 | -1,849 | -1,628 | -1,202 | -1,371 |
Proceeds from Sale of Investments | 2,128 | 1,769 | 1,343 | 1,518 | 921.36 |
Proceeds from Business Divestments | 608.5 | - | -2.99 | 0.32 | - |
Other Investing Activities | - | 1.28 | 29.5 | 16.49 | 160.05 |
Investing Cash Flow | -29.41 | -96.06 | -291.14 | 296.59 | -306.32 |
Long-Term Debt Issued | 30.9 | 36.2 | 61.71 | 17.75 | - |
Long-Term Debt Repaid | -24.64 | -30.59 | - | -26.92 | - |
Net Long-Term Debt Issued (Repaid) | 6.26 | 5.61 | 61.71 | -9.17 | - |
Issuance of Common Stock | 1.58 | 0.79 | 5.09 | 0.17 | 717.32 |
Repurchase of Common Stock | - | -36.06 | -9.07 | -48.08 | -27.31 |
Net Common Stock Issued (Repurchased) | 1.58 | -35.27 | -3.98 | -47.91 | 690.01 |
Other Financing Activities | - | -1 | -9.07 | -25.68 | -39.98 |
Financing Cash Flow | 7.84 | -30.67 | 48.66 | -82.76 | 650.03 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 3.6 | -3.4 | -6.47 | -9.49 | 2.43 |
Net Cash Flow | -82.63 | -129.63 | -29.69 | -64.26 | 141.91 |
Free Cash Flow | -78.81 | -17.44 | 186.65 | -305.26 | -220.62 |
FCF Margin | -14.37% | -2.77% | 22.27% | -71.59% | -61.95% |
Free Cash Flow Per Share | -0.45 | -0.10 | 1.07 | -1.80 | -1.39 |
Levered Free Cash Flow | 373.8 | 17.73 | 231.34 | -344.02 | -128.86 |
Unlevered Free Cash Flow | -123.75 | -62.39 | 86.45 | -381.39 | -287.76 |